Search Results - Heydrich, Björn-Niklas

Gemtuzumab ozogamicin plus midostaurin in combination with standard ‘7 + 3’ induction therapy in newly diagnosed AML: results from the SAL-MODULE phase I study by Röllig, Christoph (Author) , Schliemann, Christoph (Author) , Ruhnke, Leo (Author) , Fransecky, Lars (Author) , Heydrich, Björn-Niklas (Author) , Hanoun, Maher (Author) , Noppeney, Richard (Author) , Schäfer-Eckart, Kerstin (Author) , Wendelin, Knut (Author) , Mikesch, Jan-Henrik (Author) , Middeke, Jan Moritz (Author) , Reimann, Manja (Author) , Fiebig, Frank (Author) , Zukunft, Sven (Author) , Wermke, Martin (Author) , Serve, Hubert (Author) , Platzbecker, Uwe (Author) , Müller-Tidow, Carsten (Author) , Baldus, Claudia D. (Author) , Bornhäuser, Martin (Author) ,

• lizenzpflichtig
• lizenzpflichtig